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An Assessment of Brain Function Predicts Functional Gains in a Clinical 
Stroke Trial 
Steven C Cramer, Univ of California, Irvine, Irvine, CA; Todd B Parrish, Robert M Levy, 
Northwestern Univ Feinberg Sch of Med, Chicago, IL; Glenn T Stebbins, Rush Univ Med Ctr, 
Chicago, IL; Sean D Ruland, Univ of Illinois at Chicago, Chicago, IL; David W Lowry, The 
Brain and Spine Ctr, Holland, Ml; Theodore P Trouard, Scott W Squire, Martin E Weinand, 
Univ of Arizona, Tucson, ti.Z.; Steven B Wilkinson, Midwest Brain and Spine Associates, 
Independence, MO; Jenifer Juranek, Szu-Yun Leu, Univ of California, Irvine, Irvine, CA; 
David M Himes, Northstar Neuroscience, Inc, Seattle, WA 
INTRODUCTION: A number of therapies are in development to restore brain function after injury. 
Injuries and their effects vary widely, emphasizing the need to define which patients will 
respond to such interventions. The current study hypothesized that a baseline measure of brain 
function would have independent value for predicting subsequent therapeutic gains. METHODS: 
In a clinical trial evaluating 6 weeks of rehabilitation therapy, with or without investigational 
motor cortex stimulation, 24 patients with chronic stroke underwent baseline clinical 
assessment and functional MRI (fMRI), 6 weeks therapy, then repeat of clinical and fMRI 
assessments. The primary clinical outcome measure was arm motor Fugl-Meyer (FM) score. 
RESULTS: Across all patients, bivariate analysis found that gains in FM score over the period 
of treatment were predicted by three measures : baseline FM score, infarct volume, and 
baseline degree of motor cortex activation during hand movement at fMRI. Multivariate 
regression across all patients found that lower baseline motor cortex activation and higher FM 
score were independent predictors of greater FM score gains. CONCLUSIONS: The effects of 
therapies acting on the brain can be predicted in part by measuring baseline brain function. 
These findings will be informative for clinical decision-making. 
